Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/20/2003US6566061 Diagnosing glandular disorders and psychological disorders; obtain tissue sample, detect polymorphism, evaluate for glandular and psychological disorders
05/20/2003US6566057 Methods and compositions for peptide libraries displayed on light-emitting scaffolds
05/20/2003US6566056 Diagnosing cancer in humans; obtain genetically engineered cell, monitor gene expression adjustment and phenotypes, compare to control, evaluate for cancer
05/20/2003US6566054 Cyclin dependent kinase mutants, and diagnostic and therapeutic uses related thereto
05/20/2003US6565858 Human ADAMTS-1 protein and pharmaceutical composition
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565856 Polypeptide; inducting immunology response
05/20/2003US6565855 Polypeptides; genetic engineering
05/20/2003US6565854 Killing microorganisms, especially human pathogens; use in would dressings; animal feeds; vaccines
05/20/2003US6565852 Tumor antigen; vaccine; antitumor, anticarcinogenic agents
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
05/20/2003US6565844 Protein production and protein delivery
05/20/2003US6565843 Protein-induced tissue morphogenesis
05/20/2003US6565842 Crosslinking gel
05/20/2003US6565841 Pulmonary administration of granulocyte colony stimulating factor
05/20/2003US6565827 Anticarcinogenic agents
05/20/2003CA2262001C Mhc binding peptide oligomers and methods of use
05/20/2003CA2223579C Novel recombinant temperature sensitive mutants of influenza
05/20/2003CA2215534C Stable protein: phospholipid compositions and methods
05/20/2003CA2208013C Recombinant dna molecules and expression vectors for erythropoietin
05/20/2003CA2131551C Conjugates formed from heat shock proteins and oligo- or polysaccharides
05/20/2003CA2102302C Recombinant defective adenoviruses expressing cytokines for an antitumoral treatment
05/20/2003CA2099994C Phenyl amidines derivatives useful as platelet aggregation inhibitors
05/15/2003WO2003040726A2 Screening for hepatitis c virus entry inhibitors
05/15/2003WO2003040722A1 Means and methods for the detection of immunoglobulin capable of binding to mycobacterium antigen
05/15/2003WO2003040695A2 Protein knobs
05/15/2003WO2003040403A1 Functional assay for genes involved in xylogenesis
05/15/2003WO2003040394A2 Production of recombinant proteins in vivo and use for generating antibodies
05/15/2003WO2003040391A2 Method for producing and identifying soluble protein domains
05/15/2003WO2003040374A1 METHODS AND COMPOSITIONS FOR ENHANCED PROTEIN EXPRESSION AND/OR GROWTH OF CULTURED CELLS USING CO-TRANSCRIPTION OF A Bcl2 ENCODING NUCLEIC ACID
05/15/2003WO2003040372A2 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040370A1 Weed controller metabolism proteins, genes thereof and use of the same
05/15/2003WO2003040369A2 Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines
05/15/2003WO2003040368A2 Pharmaceutical compositions of marine sponge microciona prolifera
05/15/2003WO2003040363A1 Rice transposon genes
05/15/2003WO2003040356A1 The intact hepatitis c virus and the method for culturing it in a vitro cell culture
05/15/2003WO2003040352A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040344A2 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003WO2003040340A2 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
05/15/2003WO2003040337A2 Polyamide modulators of cox2 transcription
05/15/2003WO2003040335A2 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
05/15/2003WO2003040333A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003WO2003040332A2 Neuroglobin is up-regulated by and protects neuronsfrom hypoxic-ischemic injury
05/15/2003WO2003040330A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040327A2 Novel human proteins, polynucleotides encoding them and methods of using the same
05/15/2003WO2003040326A2 Methods and materials relating to prokineticin-like polypeptides and polynucleotides
05/15/2003WO2003040325A2 Novel proteins and nucleic acids encoding same
05/15/2003WO2003040323A2 Bacterial ion channel and a method for screening ion channel modulators
05/15/2003WO2003040322A2 Promoters for regulation of gene expression in plant roots
05/15/2003WO2003040313A2 Il-21 antagonists
05/15/2003WO2003040312A2 Multifunctional green fluorescent protein and uses thereof
05/15/2003WO2003040311A2 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
05/15/2003WO2003040310A2 Novel epidermal growth factor protein and gene, and methods of use therefor
05/15/2003WO2003040309A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003WO2003040307A2 Heteromultimeric tnf ligand family members
05/15/2003WO2003040306A2 Compositions from the grasses lolium perenne and festuca arundinacea
05/15/2003WO2003040305A2 Porcine adenovirus e1 and e4 regions
05/15/2003WO2003040304A2 Method of proliferation in neurogenic regions
05/15/2003WO2003040301A2 Cell cycle progression proteins
05/15/2003WO2003040299A2 Method of selecting hla-dp4 ligands and the applications thereof
05/15/2003WO2003040297A2 New protein of the defensin family from oil palm
05/15/2003WO2003040296A2 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003040295A2 Ion channel
05/15/2003WO2003040293A2 Genes coding for stress resistance and tolerance proteins
05/15/2003WO2003040292A2 Genes encoding for membrane synthesis and membrane transport proteins
05/15/2003WO2003040290A2 Genes from corynebacterium glutamicum that code for homeostasis proteins and for adaptation proteins
05/15/2003WO2003040286A2 Cdw92 molecule induced immunomodulation
05/15/2003WO2003040187A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
05/15/2003WO2003040184A1 Novel protein and dna thereof
05/15/2003WO2003040183A2 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
05/15/2003WO2003040181A2 Genes from the corynebacterium glutamicum coding for regulatory proteins
05/15/2003WO2003040180A2 Genes of corynebacterium glutamicum encoding for genetic stability, gene expression and folding proteins
05/15/2003WO2003040179A1 High level constitutive production of anthrax protective antigen
05/15/2003WO2003040178A1 Method for identifying or screening anti-viral agents
05/15/2003WO2003040177A2 Nucleic acid derived from an alpv virus, compositions containing said nucleic acid and uses thereof
05/15/2003WO2003040175A1 Conjugate for treating by boron neutron capture (bnc) radiation-resistant tumours
05/15/2003WO2003040169A2 Human monoclonal antibodies to dendritic cells
05/15/2003WO2003040168A2 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
05/15/2003WO2003040164A2 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003WO2003040094A2 Methods for preparation of macrocyclic molecules macrocyclic molecules prepared thereby and substrates and solid supports for use therein
05/15/2003WO2003039587A1 Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors
05/15/2003WO2003039577A1 Remedies for dry eye and diseases associated with dry eye
05/15/2003WO2003039576A1 Psp-94: use for treatment of hypercalcemia and bone metastasis
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039572A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
05/15/2003WO2003039555A2 Agents for treating lesions of the nervous system
05/15/2003WO2003039491A2 Novel isoforms of vascular endothelial cell growth inhibitor
05/15/2003WO2003039484A2 Novel compositions and methods for cancer
05/15/2003WO2003039477A2 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
05/15/2003WO2003039470A2 Polyvalent immunogen of hiv
05/15/2003WO2003039462A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003WO2003039454A2 Beta-secretase inhibitors and methods of use
05/15/2003WO2003039441A2 Unc-13 in the modulation of neurotransmission and secretion events
05/15/2003WO2003039438A2 Pna-conjugates for treating chronic myeloid leukaemia (cml)
05/15/2003WO2003039348A2 Intracellular signaling molecules
05/15/2003WO2003039346A2 Diagnostics and therapeutics for ocular abnormalities
05/15/2003WO2003039327A2 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof
1 ... 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 ... 2916